July 1 was designated as Doctor’s Day by the Government of India in 1991 to honour the memory of Dr…
July 1 was designated as Doctor’s Day by the Government of India in 1991 to honour the memory of Dr…
When governments have to weigh public health against IP issues, LDCs and developing countries really have no choice but to…
Two reports, released in early June, have both good news and bad news for the pharma industry in India
The cloak of altruism does not quite fit the blood transfusion value chain in this country
In the aftermath of this year’s USTR Special 301 Report, which retained India on the Priority Watch List, industry leaders…
Govt officials promote India as ‘Healthcare provider to the world’
India once again made it to the Priority Watch list of the 2015 USTR Special 301 Report, but this year,…
On one hand, doctors and nurses employed in the National Health Mission (NHM) were forced to go on strike to…
As Prime Minister Modi completes a year in office this May, there will no doubt be many lists of this…
Since 2013, Novartis has sharpened focus, with last April’s asset swaps with GSK and Eli Lilly the next step in…
As we settle into FY2016, it is worth taking a quick look at some of the earning previews of the…
To say that this year’s union budget was a disappointment for the healthcare sector is an understatement
Success hinges on the company getting its GMP right and surviving the glare of regulatory scrutiny
Poor logistics and supply chain management (SCM) has been identified as one of the major stumbling blocks in the underperformance…
India’s healthcare sector presents a unique proposition to entrepreneurs and investors
Finance Minister Arun Jaitley’s first Union Budget had nothing special for the pharmaceutical industry
The healthcare sector had great expectations from the Union Budget 2015-16 but reality did not live up to the hype
Other topics at the ASSOCHAM Pharma Summit included changes in drug pricing, the impending revision of NLEM-2011, and amendments in…